Tesamorelin

Tesamorelin is a synthetic 44-amino-acid peptide analogue of human growth hormone-releasing hormone (GHRH), featuring an N-terminal trans-3-hexenoic acid modification that enhances its stability and receptor affinity. It functions as a GHRH receptor agonist to stimulate endogenous, pulsatile growth hormone release, making it a powerful research tool for examining pituitary signaling, metabolic regulation, and body composition responses.

Research involving Tesamorelin commonly explores:

• Activation of the endogenous growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis for metabolic modulation.
• Reduction of visceral adipose tissue and improvement in lipid metabolism.
• Enhancement of mitochondrial function and bioenergetics in muscle.
• Investigations into peripheral nerve regeneration, cognitive aging, and sarcopenia models.
Tesamorelin is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.

Product details:

• Synonyms: (3E)-hex-3-enoylsomatoliberin, TH-9507, Egrifta
• Purity: ≥98%
• CAS Number: 901758-09-6
• Molecular Formula: C221H366N72O67S
• Molecular Weight: 5136 Da
• Amino Acid Sequence (single-letter code): Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.